Current share price for RMD : $27.750 0.03 (0.11%)+
ResMed Inc (RMD), an ASX-listed company, works to increase awareness of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company provides diagnoses and develops treatments for these conditions for people worldwide.
| ASX Code | RMD |
| Website | http://www.resmed.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 15,849 |
| RMD Share Price | $27.750 |
| Day High | $28.050 |
| Day Low | $27.640 |
| Last Close | $27.720 |
| RMD Share Price Movement | $0.03 ( 0.11% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 5.82¢ | 0% | 13 May 2026 | 18 Jun 2026 | - | - | - |
| Result | 5.92¢ | 0% | 11 Feb 2026 | 19 Mar 2026 | - | - | - |
| Result | 6.43¢ | 0% | 12 Nov 2025 | 18 Dec 2025 | - | - | - |
See all dividends from ResMed Inc. (RMD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $2,235.46 | $151.45 | 10.20% | 25.03 | 44.61 | 1.18% | 0.0% |
| 2025F | $2,028.91 | $137.46 | 16.70% | 27.58 | 34.38 | 0.91% | 0.0% |
| 2024A | $1,737.52 | $117.75 | 23.10% | 23.39 | 30.04 | 1.09% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Cochlear Limited (COH) | $6,729M | 0.0171 | -0.1883 | 0.0862 | 17.1933 | 21.1817 | 19.5015 | 4.18% | 3.37% | 3.60% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $18,658M | 0.1388 | 0.1347 | 0.1883 | 48.0417 | 42.3374 | 35.6286 | 1.36% | 1.46% | 1.65% |
| ResMed Inc. (RMD) | $15,976M | 0.3087 | 9.7634 | 0.0805 | 192.3659 | 17.8722 | 16.5405 | 1.20% | 1.26% | 1.32% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.45 | 18.50 | 4.45 | 0.08 |
| Market | 0.58 | 17.20 | 1.57 | 1.05 |
| Sector | 0.60 | 21.10 | 1.57 | 3.14 |
| Name | Position | Start Date |
|---|---|---|
| Mr Michael J Farrell | Chief Executive Officer, Executive Director | 1 Mar 2013 |
| Mr Ronald R Taylor | Non-Executive Director | 25 Jan 2005 |
| Ms Carol Burt | Non-Executive Director | 11 Aug 2014 |
| Ms Karen Ruth Drexler | Non-Executive Director | 17 Nov 2017 |
| Mr Jan De Witte | Non-Executive Director | 16 May 2019 |
| Ms Harjit Gill | Non-Executive Director | 15 Nov 2018 |
| Dr John Hernandez | Non-Executive Director | 19 Nov 2021 |
| Dr Desney Tan | Non-Executive Director | 19 Nov 2021 |
| Mr Christopher DelOrefice | Non-Executive Director | 19 Aug 2024 |
| Ms Nicole Mowad Nassar | Non-Executive Director | 15 Aug 2025 |
| Dr Peter Craig Farrell | Non-Executive Director, Non-Executive Chairman | 1 Jul 2002 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 2 Jul 2024 | ROBERTS, Christopher | Issued | Options | 12,000 | $50.950 | $611,400.000 |
| 19 Aug 2011 | FARRELL, Peter | Sell | Direct Shares | 200,000 | $0.000 | |
| 17 Aug 2011 | FARRELL, Peter | Issued | Related Securities | 28,571 | $0.000 |
See all changes in directors' interest & trades for ResMed Inc. (RMD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Brett A Sandercock | Chief Financial Officer, (Principal Financial Officer and Principal Accounting Officer) |
| Date | Event |
|---|---|
| 10 August 2026 | Report (Annual) |
| 18 June 2026 | Div Pay Date |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.